Timing is everything: Where status epilepticus treatment fails

Ann Neurol. 2017 Aug;82(2):155-165. doi: 10.1002/ana.24986. Epub 2017 Jul 29.

Abstract

Status epilepticus is an emergency; however, prompt treatment of patients with status epilepticus is challenging. Clinical trials, such as the ESETT (Established Status Epilepticus Treatment Trial), compare effectiveness of antiepileptic medications, and rigorous examination of effectiveness of care delivery is similarly warranted. We reviewed the medical literature on observed deviations from guidelines, clinical significance, and initiatives to improve timely treatment. We found pervasive, substantial gaps between recommended and "real-world" practice with regard to timing, dosing, and sequence of antiepileptic therapy. Applying quality improvement methodology at the institutional level can increase adherence to guidelines and may improve patient outcomes. Ann Neurol 2017;82:155-165.

Publication types

  • Review

MeSH terms

  • Anticonvulsants / therapeutic use*
  • Guideline Adherence
  • Humans
  • Status Epilepticus / drug therapy*
  • Time-to-Treatment / statistics & numerical data*

Substances

  • Anticonvulsants